IV Medications Elsevier app analytics for November 26

IV Medications Elsevier

IV Medications Elsevier

  • Skyscape Medpresso Inc
  • Apple App Store
  • Free
  • Medical
"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. Use the #1 IV drug handbook to safely administer more than 400 intravenous drugs! Includes the most recent IV drugs to be approved by the FDA Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2024 edition are 8 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings. KEY FEATURES - Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference. - Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more. - Additional drug monographs are provided on the Evolve website. - Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks. - Blue-screened text calls attention to special circumstances not covered by Black Box Warnings. - Dosage and dilution charts within monographs provide quick summaries of essential clinical information. - Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients. - Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds. Content licensed from printed edition ISBN-10: 0443121109 Content licensed from printed edition ISBN-13: 9780443121104 SUBSCRIPTION : Please purchase a yearly auto-renewing subscription to receive content access and available updates. Yearly auto-renewing payments- $49.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Author(s):Shelly Rainforth Collins, PharmD Publisher:Elsevier Health Sciences
IV Medications Elsevier

Store Rank

The Store Rank is based on multiple parameters set by Google and Apple.

All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us

IV Medications Elsevier Ranking Stats Over Time

Similarweb's Usage Rank & Apple App Store Rank for IV Medications Elsevier

Rank

No Data Available

IV Medications Elsevier Ranking by Country

Counties in which IV Medications Elsevier has the highest ranking in its main categories

No Data to Display

Top Competitors & Alternative Apps

Apps with a high probability of being used by the same users, from the same store.

IV Medications Gahart

IV Medications Gahart

Unbound Medicine, Inc.

Mosby's Drug Reference

Mosby's Drug Reference

Unbound Medicine, Inc.

RNotes®

RNotes®

Unbound Medicine, Inc.

PEPID®

PEPID®

PEPID, LLC

IV Medications Elsevier VS.

November 26, 2024